2,021 results on '"Martelletti, Paolo"'
Search Results
2. Hallmarks of primary headache: part 1 – migraine
3. Situational prevention in migraine: are we doing the right thing?
4. Unveiling a groundbreaking alliance: the inaugural collaboration between the Asian Regional Consortium of Headache and The Journal of Headache and Pain
5. The Preoperative Assessment of Frailty in the Setting of Transcatheter Aortic Valve Implantation (TAVI): A Systematic Review
6. The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study
7. Mechanosensitive receptors in migraine: a systematic review
8. The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders
9. Unmet Needs in the Acute Treatment of Migraine
10. The measurement of the left ventricle ejection fraction by a bedside FoCUS examination
11. Long-Term Effects of COVID-19 and ICU on Headache Disorders
12. What Is the Best Methodology for Headache or Migraine Research?
13. Tension-Type Headache
14. Other Non-migraine Primary Headache Disorders
15. Trigeminal Autonomic Cephalalgias
16. What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?
17. Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030
18. COVID-19 vaccination-related headache showed two different clusters in the long-term course: a prospective multicenter follow-up study (COVA-Head Study)
19. Debate: differences and similarities between tension-type headache and migraine
20. The Point-of-Care Ultrasound (POCUS) by the Handheld Ultrasound Devices (HUDs) in the COVID-19 Scenario: a Review of the Literature
21. Efficiency of occlusal splint therapy on orofacial muscle pain reduction: a systematic review
22. The Migraine Stigma Kaleidoscope View
23. New Migraine Drugs for Older Adults
24. Unmet Needs in Preventive Treatment of Migraine
25. Treatment
26. Diagnosis
27. Mechanisms
28. Future Directions
29. Public Health
30. Zavegepant
31. Stigma and Chronic Pain
32. The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization
33. Migraine Versus Cluster Headache and Potential Other Indications
34. Fremanezumab
35. The preclinical discovery and development of atogepant for migraine prophylaxis
36. Practical Insights on the Identification and Management of Patients with Chronic Migraine
37. Migraine Outcome Should Not Be Used to Determine Diagnosis, Severity, and Therapy: Moving Towards a Multiparametric Definition of Chronicity
38. Prophylactic Drugs
39. Long COVID and especially headache syndromes
40. Long COVID headache
41. European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
42. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
43. Narrative-based medicine in headache disorders
44. Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
45. The Global Campaign turns 18: a brief review of its activities and achievements
46. Thiamine Deficiency in the Pathophysiology and Diagnosis of Wernicke-Korsakoff Syndrome: Case Report and Literature Review
47. Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN
48. Understanding the efficacy and tolerability of migraine treatment: a deep dive into CGRP antagonists.
49. Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine.
50. Non-Migraine Head Pain and Botulinum Toxin.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.